These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10748050)

  • 1. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF.
    Wang D; Donner DB; Warren RS
    J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
    Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
    Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.
    Shen BQ; Lee DY; Cortopassi KM; Damico LA; Zioncheck TF
    J Biol Chem; 2001 Feb; 276(7):5281-6. PubMed ID: 11058594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
    Shore VH; Wang TH; Wang CL; Torry RJ; Caudle MR; Torry DS
    Placenta; 1997 Nov; 18(8):657-65. PubMed ID: 9364601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
    Kaipainen A; Korhonen J; Pajusola K; Aprelikova O; Persico MG; Terman BI; Alitalo K
    J Exp Med; 1993 Dec; 178(6):2077-88. PubMed ID: 8245783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
    Suzuma K; Naruse K; Suzuma I; Takahara N; Ueki K; Aiello LP; King GL
    J Biol Chem; 2000 Dec; 275(52):40725-31. PubMed ID: 11018037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
    J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
    Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
    J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.